ResearcherUniversity of PennsylvaniaNo recent work listed

Todd W. Ridky

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8482-1284; OpenAlex author ID A5085814203. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.jcmgh.2020.04.016 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert J. Norgard · 1 shared paper, 2020 · strength 0.11
- Paper Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.04.016 ↗
Jinyang Li · 1 shared paper, 2020 · strength 0.11
- Paper Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.04.016 ↗
Christopher A. Natale · 1 shared paper, 2020 · strength 0.11
- Paper Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.04.016 ↗
Ben Z. Stanger · 1 shared paper, 2020 · strength 0.11
- Paper Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.04.016 ↗
Jason Robert Pitarresi · 1 shared paper, 2020 · strength 0.11
- Paper Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2020.04.016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.